Inflammatory cytokine profiles of patients suffering from severe and critical forms of COVID-19 or various types of cancer revealed a potential crossing point, namely significantly elevated serum levels of pro-inflammatory cytokine IL-6 (Brábek et al. This evidence concerns the gene IL6 and cancer.